Back
Maze Therapeutics, Inc. 10K Form
Buy
64
MAZE
Maze Therapeutics, Inc.
Last Price:
$42.58
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MAZE News And Ratings
See the #1 stock for the next 7 days that we like better than MAZE
MAZE Financial Statistics
Sales & Book Value
| Annual Sales: | $167.5M |
|---|---|
| Cash Flow: | $-24.7M |
| Price / Cash Flow: | 8 |
| Annual Sales: | $7.89 |
| Price / Book: | 5.4 |
Profitability
| EPS (TTM): | -2.25440 |
|---|---|
| Net Income (TTM): | $-86.5M |
| Gross Margin: | $164.2M |
| Return on Equity: | -35.16% |
| Return on Assets: | -28.99% |
Maze Therapeutics, Inc. Earnings Forecast
Key Maze Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 3 years for MAZE is 98.03%.
-
The Selling, General & Administrative Expenses for MAZE have been equal to 15.77% of Gross Profit Margin.
-
The Research & Development expenses have been 49.85% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of MAZE is 10.97% of Total Revenues.
-
Per Share Earnings over the last 3 years have been positive in 2 years.
Maze Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Current Symbol: | MAZE |
| Website: | mazetx.com |
Debt
| Debt-to-Equity Ratio: | 0.06 |
|---|---|
| Current Ratio: | 17.7 |
| Quick Ratio: | 17.36 |
Price-to-Earnings
| Trailing P/E Ratio: | 547.56 |
|---|---|
| Forward P/E Ratio: | 0 |
MAZE Technical Analysis vs Fundamental Analysis
Buy
64
Maze Therapeutics, Inc. (MAZE)
is a Buy
Is Maze Therapeutics, Inc. a Buy or a Sell?
-
Maze Therapeutics, Inc. stock is rated a BuyThe current Maze Therapeutics, Inc. [MAZE] share price is $42.60. The Score for MAZE is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.